18. Jul 2017
4SC AG: Developing innovative drugs for cancer patients
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on clinical development.
We develop novel small molecule drugs for the treatment of cancer in indications with a high unmet medical need and major economic potential.
We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.
Our product pipeline comprises promising drug programs at various stages of clinical development. We are focusing on fields of research with an especially promising future – such as epigenetics, cancer stem cells, cancer immunotherapy and other, important cell signaling pathways that contribute to the development and persistence of cancer.